In a preliminary report (Zuckner, 1961) This study has been continued, and in the ensuing 18 months another 820 injections have been evaluated. Other steroids were also tried for comparison of their antirheumatic effectiveness by intramuscular administration. These included the depot preparation of 6-methyl prednisolone (referred to as DM)", triamcinolone acetonide tertiary-butylacetate (TATBA)t, and triamcinolone acetonide monoenanthate (TM) §. The chemical formulae of these preparations are shown in the figure opposite. Procedure TACTN, TDAC, DM, TATBA, and TM were injected intramuscularly into 86 patients with rheumatoid arthritis. These patients were classified (Table I) according to criteria of Steinbrocker, Traeger, and Batterman (1949) , the majority being in Stage II, Class II. Their ages ranged from 32 to 75 years, most being in their fifties. There were 66 females and twenty males. The duration of disease was less than 5 years in about 40 per cent. and more than 10 years in one-third of the cases. Disease activity was graded 1 to 4 plus, and approximately 90 per cent. of the patients were considered to have 2 or 3 plus changes at the onset of the study. There were 900 injections of 100 mg. each. The amount of steroid injected was varied in a few individuals in an attempt to determine an optimum dose. Ten patients received a total of eleven injections of '0 mg. TACTN and these were compared with doses of 100 mg. TACTN in the same individuals. Nine injections of 140 mg. TACTN were compared with a 100-mg. dose in six cases. One hundred or more injections each of TACTN, TDAC, and DM were administered to 53, 47, and 68 patients, respectively (Table II, opposite) .
In a preliminary report (Zuckner, 1961) on intramuscular steroid therapy in patients with rheumatoid arthritis, results of approximately 100 injections of triamcinolone acetonide (hereafter referred to as TACTN)* and triamcinolone diacetate (or TDAC)t were described. The responses to this method of steroid administration were satisfactory in most cases, and compared favourably with those following the oral administration of steroids. In about 25 per cent. of cases, the anti-rheumatic effect was superior.
This study has been continued, and in the ensuing 18 months another 820 injections have been evaluated. Other steroids were also tried for comparison of their antirheumatic effectiveness by intramuscular administration. These included the depot preparation of 6-methyl prednisolone (referred to as DM)", triamcinolone acetonide tertiary-butylacetate (TATBA)t, and triamcinolone acetonide monoenanthate (TM) §. The chemical formulae of these preparations are shown in the figure opposite. Procedure TACTN, TDAC, DM, TATBA, and TM were injected intramuscularly into 86 patients with rheumatoid arthritis. These patients were classified (Table I) according to criteria of Steinbrocker, Traeger, and Batterman (1949) , the majority being in Stage II, Class II. Their ages ranged from 32 to 75 years, most being in their fifties. There were 66 females and twenty males. The duration of disease was less than 5 years in about 40 per cent. and more than 10 years in one-third of the cases. Disease activity was graded 1 to 4 plus, and approximately 90 per cent. of the patients were considered to have 2 or 3 plus changes at the onset of the study. There were 900 injections of 100 mg. each. The amount of steroid injected was varied in a few individuals in an attempt to determine an optimum dose. Ten patients received a total of eleven injections of '0 mg. TACTN and these were compared with doses of 100 mg. TACTN in the same individuals. Nine injections of 140 mg. TACTN were compared with a 100-mg. dose in six cases. One hundred or more injections each of TACTN, TDAC, and DM were administered to 53, 47, and 68 patients, respectively (Table II, opposite) .
Most injections (532) were of DM. A few injections of hydrocortisone acetate (FACt) in 500-mg. doses were also included for comparison; 22 patients received twenty or more injections; the greatest number for one patient was 38.
The different steroids were compared in individual cases only if at least two injections of each hormone were administered. In this manner, two, three, four, or, occasionally, all five steroids were evaluated in the same individual.
Thus, it was possible to compare TACTN, for example, with TDAC in 23 cases, with DM in 22, with TM in seven, and with TATBA in ten cases. TDAC and DM were compared with the other steroids almost as frequently as described for TACTN. TM and TATBA were similarly evaluated about half as often.
During the study, not all the steroids mentioned were available at the same time. Therefore, it was not possible to rotate all the preparations at subsequent injection times in the same individual; however, the same steroid was usually not administered twice in succession. This random variation was done deliberately in an effort to minimize interfering factors which could appear from 456 Patients were usually examined once weekly at first, but with more prolonged observation, the interval between visits was lengthened to 2 to 4 weeks. The joints were evaluated at each visit for subjective improvement in pain, stiffness, and changes in mobility, and for objective improvement in tenderness, heat, swelling, range of motion, capsular thickening, and amount of synovial fluid present. A composite estimate of these findings was recorded as a percentage.
The interval between injections was usually determined by the patient's subjective response, particularly the return of significant pain. A degree of improvement greater than 50 per cent. was the intent in each subject, and a worsening to this level or lower after initial improvement was the indication for another injection. Although an effort was made to maintain improvement at a satisfactory level (50 per cent. or better), some of the patients dropped below this figure for a few days before their next injection of steroid.
The duration of observation varied (Table III) .
Approximately half the patients were studied for 1 year or more, and seven of these for more than 2 years.
Other therapy was continued as prescribed before the study was instituted with the exception of orally-adminis- At times there was a variability in response between one injection and the next. Thus, it was possible for a specific steroid to give satisfactory improvement after one injection, which was followed by a poor response after the next injection. This occurred with all the steroids studied, and its cause was not apparent. In many instances, there was no marked deterioration to indicate that any change had occurred which could have reduced the effectiveness of steroid therapy. However, a third dose of the same hormone often had a beneficial result once again.
The onset of improvement after an intramuscular steroid injection was usually first noted on awakening the next morning. A few patients experienced relief in as little as 3 to 5 hours after an injection, and some not until 48 hours afterwards. The improvement was most often at its maximum on the day after injection, but in a few individuals it gradually reached its maximum after several days.
Simultaneous treatment with salicylates and gold salts had no significant effect on the results. It was possible to discontinue the oral use of steroids in 27 of 38 patients who had been receiving oral steroids at the start of the study. It was usually easier to reduce the oral dose gradually, particularly if one were waiting for the total dosage of gold salts to accumulate to a therapeutic level in the body tissues. If doses of oral steroids were less than the equivalent of 12-5 mg. of prednisolone daily, abrupt discontinuation at the time of the first intramuscular injection was frequently possible.
In approximately 25 per cent. of patients, intramuscular steroid therapy proved more satisfactory than oral. Only a few individuals expressed preference for the oral route. In ten patients a combination of intramuscular and oral steroids proved more beneficial than either alone.
Side-Effects The significant side-effects are shown in Table V . (West, 1962; Norcross and Winter, 1961; Hartfall, Walker, and Wright, 1962; Schwartz, 1963) in the literature confirm this impression of the efficacy of intramuscular steroid therapy. West (1962) treated sixteen patients with weekly intramuscular injections of prednisolone acetate for 31 years with favourable responses, the antiinflammatory effect being about the same as with oral steroids. Norcross and Winter (1961) injected DM intramuscularly; they felt that it offered certain advantages over oral steroids in selected patients, but did not recommend it for routine administration. Hartfall and others (1962) gave prednisolone trimethylacetate intramuscularly to seventeen patients and reported improvement in nine. Schwartz (1963) found intramuscular steroids valuable for long-term treatment, his patients being improved for 14 to 21 days after one injection of 40 mg. TACTN. In our study, about 25 per cent. of patients responded better to intramuscular than to oral steroids, and about 10 per cent. seemed to be better when oral and intramuscular steroids were used simultaneously.
INTRAMUSCULAR STEROIDS Side-effects.-The known side-effects of oral steroids were also observed with intramuscular therapy, the frequency and severity of the reactions depending to a great extent on the interval between injections. If 4 weeks or more elapsed between injections, such side-effects as moon facies, hirsutism, and acne, for example, were less frequent and less intense. Since it was possible to obtain satisfactory therapeutic responses in many patients with such widely-spaced injections, this method proved more desirable for them. Injections given more often than once every 3 weeks were followed by complications similar to or more severe than those due to oral steroids. Consequently, the interval between injections should be as long as possible; they should be repeated only when considered essential because of significant worsening in the patient's condition, and not given routinely at set intervals.
The dose per injection is also very important when considering side-effects, but as 100 mg. was used for the majority of injections in this study, a proper evaluation of the relationship of dose to toxicity was not possible.
The various authors who have used the intramuscular route have all concluded that gastrointestinal complications are definitely fewer than with oral steroids, and this has also been our experi- pro- longed response which followed the intramuscular injections of TACTN, TDAC, DM, TM, and TATBA is not known. A "depot" effect may partly explain it, and to test this, five of our patients were given DM intramuscularly and tablets of 6-methyl prednisolone orally in the same 100 mg. dose, but at different times. Oral therapy gave 2 days' improvement, whereas the intramuscular route gave 3 weeks. This type of information supports the likelihood of a "depot" effect. However, certain unknown factors (such as, the rate of absorption through the gastrointestinal tract of the orally administered steroid, the amount absorbed, and the importance of passage through the portal circulation as the initial pathway for the steroid) require evaluation. The development of better methods of assaying the blood levels of these steroids should give definite answers. The prolonged response may be due to an initial high blood level of the drug resulting from the large dose injected. Higher concentrations of steroid may thus enter the inflamed synovial cells and suppress the inflammation more efficiently, particularly if the permeability of these cells is altered by inflammation. Passage through the systemic circulation before the portal circulation, thus temporarily avoiding the effect of the liver cells on the metabolism of the steroids, may also leave more steroids available to enter the inflamed synovial cell. However, since the steroid levels may be assumed to have been high in the blood of the patients who received 100 mg. 6-methyl prednisolone orally, but responded poorly, the significance of this explanation is doubtful. Summary The intramuscular administration of steroids in an attempt to combine a good anti-inflammatory response with relatively minor toxicity was tested in a series of 920 injections. The desired anti-inflammatory effect was obtained in approximately 70-85 per cent. of instances with 100 mg. injections of TACTN, TDAC, DM, TM, and TATBA, most frequently with TACTN. The duration of improvement was greatest following the administration of TACTN (average 20 5 days per injection). A 50-mg. dose of TACTN was significantly less satisfactory than the 100 mg. dose. The greater improvement in a few patients after a 140-mg. dose of TACTN did not seem to warrant the use of this large dose routinely because of the greater risk of toxicity.
Evaluation of toxic side-effects will require more prolonged observation, but there is evidence that if injections are relatively widely spaced (i.e. more than 
